Full Press Release Details
| Media Contacts | Investor Contacts | |
| Jennifer Albano | Steve Frank | |
| 1-973-945-4333 (o) | 1-973-822-7141 (o) | |
| jennifer.albano zoetis.com | steve.frank zoetis.com | |
| Laura Panza | Nick Soonthornchai | |
| 1-973-975-5176 (o) | 1-973-443-2792 (o) | |
| laura.panza zoetis.com | nick.soonthornchai zoetis.com |
Zoetis Declares Second Quarter 2025 Dividend
PARSIPPANY, N.J. - February 6, 2025 -The Board of Directors of Zoetis Inc. (NYSE ZTS) has declared a dividend of $0.500 per share for the second quarter of 2025. The dividend will be paid on Tuesday, June 3, 2025, to all holders of record of the Company's common stock as of the close of business on Monday, April 21, 2025.
As the world's leading animal health company, Zoetis is driven by a singular purpose to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide -- from veterinarians and pet owners to livestock producers. The company's leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.5 billion in 2023 with approximately 14,100 employees. For more information, visit www.zoetis.com.
Forward-Looking Statements This press release contains forward-looking statements, which reflect the current views of Zoetis with respect to business plans or prospects, future operating or financial performance, future use of cash and dividend payments, and other future events. These statements are not guarantees of future performance or actions. Forward-looking
statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management's underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our most recent Annual Report on Form 10-K, including in the sections thereof captioned "Forward-Looking Statements and Factors That May Affect Future Results" and "Item 1A. Risk Factors," in our Quarterly Reports on Form 10-Q and in our Current Reports on Form 8-K. These filings and subsequent filings are available online at www.sec.gov, www.zoetis.com, or on request from Zoetis.